Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ferraro

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Infection Control and Hospital Epidemiology|October 30, 2010
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomesE P Hyle, M J Ferraro, M Silver, et al.
Journal of Clinical Microbiology|March 1, 1994
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamasesG P Katsanis, J Spargo, M J Ferraro, et al.
Journal of Clinical Microbiology|February 1, 1990
Evaluation of two single-plate incubation systems and the anaerobic chamber for the cultivation of anaerobic bacteriaJ Downes, J I Mangels, J Holden, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Susceptibilities of Legionella spp. to newer antimicrobials in vitroT Schülin, C B Wennersten, M J Ferraro, et al.
Journal of Clinical Microbiology|November 1, 1993
Cefuroxime screening test for pneumococciF C Tenover, J Swenson, M J Ferraro, et al.
Journal of Clinical Microbiology|January 1, 1994
Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis cariniiJ A Fishman, R S Roth, E Zanzot, et al.
Il Giornale Di Chirurgia|April 13, 2013
Primary neuroendocrine lung tumor presenting with acute ileal obstruction. Case reportG Li Destri, M J Ferraro, G Vecchio, et al.
Journal of Clinical Microbiology|October 1, 1992
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on EnterococciJ M Swenson, M J Ferraro, D F Sahm, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaG M Eliopoulos, K Klimm, C T Eliopoulos, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Infection Control and Hospital Epidemiology|October 30, 2010
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomesE P Hyle, M J Ferraro, M Silver, et al.
Journal of Clinical Microbiology|March 1, 1994
Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamasesG P Katsanis, J Spargo, M J Ferraro, et al.
Journal of Clinical Microbiology|February 1, 1990
Evaluation of two single-plate incubation systems and the anaerobic chamber for the cultivation of anaerobic bacteriaJ Downes, J I Mangels, J Holden, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Susceptibilities of Legionella spp. to newer antimicrobials in vitroT Schülin, C B Wennersten, M J Ferraro, et al.
Journal of Clinical Microbiology|November 1, 1993
Cefuroxime screening test for pneumococciF C Tenover, J Swenson, M J Ferraro, et al.
Journal of Clinical Microbiology|January 1, 1994
Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis cariniiJ A Fishman, R S Roth, E Zanzot, et al.
Il Giornale Di Chirurgia|April 13, 2013
Primary neuroendocrine lung tumor presenting with acute ileal obstruction. Case reportG Li Destri, M J Ferraro, G Vecchio, et al.
Journal of Clinical Microbiology|October 1, 1992
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on EnterococciJ M Swenson, M J Ferraro, D F Sahm, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaG M Eliopoulos, K Klimm, C T Eliopoulos, et al.
Pageof 9